The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Sep 01, 2026
Snapshot (as of Sep 01, 2026): Abbott Laboratories (ABT) pays a $2.48 annual dividend ($0.63 quarterly), yielding 2.26% at $109.66/share. Next ex-dividend date 2026-07-15. 12 consecutive years of dividend growth. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 2.26%
Annual Dividend: $2.48 per share
Payout Ratio: 78.5%
Ex-Dividend Date: 2026-07-15
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 44
Abbott Laboratories dividend has been paid every quarter for decades, backed by a global healthcare business spanning medical devices, diagnostics, nutrition, and pharmaceuticals. ABT currently yields 2.21%, with a trailing annual dividend rate of $2.48 per share. The next ex-dividend date is July 15, 2026, and the last quarterly payment was $0.63 per share. A beta of 0.581 points to below-average price volatility, which suits income investors who prioritize steadier returns over aggressive growth.
Abbott Laboratories pays out 78.5% of earnings as dividends, a payout ratio classified as high (above 75%). That level is supported by a broad, diversified revenue base spanning diagnostics, medical devices, nutritional products, and established pharmaceuticals, all of which address ongoing healthcare needs rather than discretionary spending. Abbott Laboratories dividend safety is the central question at this payout level, and the main pressure point is clear: there is limited room for earnings to soften before the dividend would require reassessment.
Abbott Laboratories dividend history shows a CAGR of 7.3% per year from 2010 to 2025. The per-share annual dividend grew from $0.8252 to $2.36 over that period (2026 is a partial year and excluded from the rate calculation). The largest annual increase in the window was 25.0% in 2021, while the data also contains at least one year-over-year decline exceeding 5%, reflecting that growth has not been perfectly linear across the full window.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +7.9% | $1.88 (2022) | $2.36 (2025) |
| 5-Year | +10.4% | $1.44 (2020) | $2.36 (2025) |
| 10-Year | +9.4% | $0.96 (2015) | $2.36 (2025) |
ABT fits dividend investors who want moderate, growing income from a diversified healthcare business rather than a high-yield payout. The current yield of 2.21% sits in the moderate (2-4%) range and is above the 5-year average of 1.83%, meaning today's entry point offers more income than the historical norm. Twelve consecutive years of dividend increases show a commitment to growth, and the 7.3% annual CAGR over 15 years is meaningful in real terms. The trade-off is a payout ratio of 78.5%, which leaves less cushion than lower-payout peers and means earnings pressure would be felt quickly at the dividend level.
| Payment Date | Amount per Share |
|---|---|
| 2026-07-15 | $0.6300 |
| 2026-04-15 | $0.6300 |
| 2026-01-15 | $0.6300 |
| 2025-10-15 | $0.5900 |
| 2025-07-15 | $0.5900 |
| 2025-04-15 | $0.5900 |
| 2025-01-15 | $0.5900 |
| 2024-10-15 | $0.5500 |
| 2024-07-15 | $0.5500 |
| 2024-04-12 | $0.5500 |
| Year | Total Dividends |
|---|---|
| 2026 | $1.8900 |
| 2025 | $2.3600 |
| 2024 | $2.2000 |
| 2023 | $2.0400 |
| 2022 | $1.8800 |
Project income from ABT with the ABT dividend calculator or track your full portfolio with the dividend tracker.